The Lawyer’s new China Elite report contains the most detailed research available on the PRC legal market and contains unparalleled insight into the country's leading law firms. They vary in size, practice focus and geographic coverage, but they all share one common quality – ambition... Read more
An exhaustive analysis of the UK market including every firm in the top 200 ranked, analysed and benchmarked, UK chambers ranked by turnover, revenue per barrister and which international firms are most active in the UK.
The tender process for the NHS Litigation Authority’s (NHSLA) clinical negligence and non-clinical negligence legal panels has begun after several false starts.
The contract will last for four years and is worth between £300m and £400m, according to the tender. Legal advice will be divided into three tranches - clinical liabilities, non-clinical liabilities, and regulatory, health and disciplinary law - with the lots expected to spend an estimated £80m, £15m and £5m respectively on legal advice over a 12-month period.
A spokesperson for the authority, which slashed its external advisers from 90 to 15 in 2002, said there are no indications that it is looking to cut the existing panel.
“We’re envisaging appointing approximately the same numbers, but there may be some flexibility, either upwards or downwards,” a spokesperson said.
Browne Jacobson, Clydes, Hill Dickinson, Kennedys, Ward Hadaway and Weightmans are all also on the non-clinical negligence panel along with Exeter firm Veitch Penny. That panel was last reviewed in 2009.
The framework will also be available to various arm’s length bodies (ALBs) under the Department of Health, including the Care Quality Commission, the Health Research Authority and the National Institute for Health and Clinical Excellence.
The tender was initially due to take place in December. A supplier day was also delayed and took place on 22 February.
In the 2011/12 financial year the NHSLA received over 9,100 new clinical negligence claims and more than 4,600 non-clinical negligence claims. It spent over £1bn on clinical negligence claims and around £50m on non-clinical negligence matters.
In April last year the authority appointed NSPCC general counsel Catherine Dixon as its new chief executive, replacing Stephen Walker.